Author:
Sharfstein Joshua M.,Conti Rena M.,Gee Rebekah E.
Abstract
AbstractThe complexity and inefficiency of the U.S. health care system complicates the distribution of life-saving medical technologies. When the public health is at stake, however, there are alternatives. The proposal for a national PrEP program published in this issue of the Journal applies some of the lessons of the national COVID vaccine campaign to HIV prevention. In doing so, it draws on other examples of public health approaches to the financing of medical technology, from vaccines for children to hepatitis C treatment.
Publisher
Cambridge University Press (CUP)
Subject
Health Policy,General Medicine,Issues, ethics and legal aspects
Reference4 articles.
1. 4. Louisiana Department of Health, “Taking Control of Hepatitis C,” October 11, 2021. available at (last visited March 21, 2022).
2. Medicaid Subscription-Based Payment Models and Implications for Access to Hepatitis C Medications
3. Benefits from Immunization during the Vaccines for Children Program Era - United States, 1994-2013;Whitney;MMWR: Morbidity and Mortality Weekly Report,2014
4. Financing and Delivering Pre-Exposure Prophylaxis (PrEP) to End the HIV Epidemic in the United States;Killelea;Journal of Law, Medicine and Ethics,2022
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献